|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
Rhinitis, allergic |
|
Urticaria, chronic idiopathic |
| |
|
|
SIDE EFFECTS:
|
|
Back pain |
|
coughing |
|
dizziness |
|
drowsiness |
|
dysmenorrhea |
|
dyspepsia |
|
fatigue |
|
fever |
|
headache |
|
nausea |
|
otitis media |
|
sinusitis |
|
viral infections such as cold, flu |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
>> Renal function impairment |
|
|
ADULT DOSE:
|
|
Rhinitis, seasonal, allergic (treatment) -
Oral, 60 mg two times a day, or 180 mg once a day .
Urticaria (treatment) -
Oral, 60 mg two times a day.
Note: For patients with decreased renal function, an initial dose of 60 mg once a day is recommended . |
|
MAXIMUM ADULT DOSE:
|
|
60 mg two times a day, or 180 mg once a day .
|
|
PEDIATRIC DOSE:
|
|
Rhinitis, seasonal, allergic (treatment)
Urticaria (treatment) -
See Fexofenadine Hydrochloride Capsules
Note: In Canada, not indicated for children younger than 12 years of age |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
30 mg two times a day
|
|
ELDERLY DOSE:
|
|
Rhinitis, seasonal, allergic (treatment)
Urticaria (treatment) -
See Usual adult and adolescent dose . |
|
|
|
|